[Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000503:physiopathology; D001809:Blood Viscosity / Q000187:drug effects; D002908:Chronic Disease; D004798:Enzymes / Q000009:adverse effects / Q000494:pharmacology; D004903:Erythrocyte Aggregation / Q000188:drug therapy; D005340:Fibrinogen / Q000032:analysis; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D012039:Regional Blood Flow; D012212:Rheology; D012910:Snake Venoms / Q000009:adverse effects / Q000494:pharmacology
D004798:Enzymes; D012910:Snake Venoms; D005340:Fibrinogen
Therapie chronischer peripherer arterieller Verschlusskrankheiten mit dem Schlangengift-Enzym Arwin